Author:
Zhang Guoqing,Mu Teng,Zhang Yan,Jiao Jia,Ding Zheng,Yang Hang,Pan Dabo,Zhao Jia,Li Jindong,Li Xiangnan
Reference24 articles.
1. Japanese Classification of Esophageal Cancer, 12th Edition: Part I, 12th Edition;Mine;Esophagus,2024
2. Japanese Classification of Esophageal Cancer, 12th Edition: Part II, 12th Edition;Doki;Esophagus,2024
3. Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer;Yokota;Anticancer Res.,2011
4. A single-arm, multicenter, phase II clinical study of tislelizumab plus albumin-bound paclitaxel/cisplatin as neoadjuvant therapy for borderline resectable esophageal squamous cell carcinoma;Li;Ann. Transl. Med.,2022
5. Paclitaxel plus cisplatin and 5-fluorouracil induction chemotherapy for locally advanced borderline-resectable esophageal squamous cell carcinoma: a phase II clinical trial;Wang;Esophagus,2022